Real-time enrollment status for this major depressive disorder (mdd) clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 6:09 AM UTC
| NCT Number | NCT07226661 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder (MDD) |
| Phase | PHASE2 |
| Target Enrollment | 230 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Supernus Pharmaceuticals, Inc. |
| Last Updated on CT.gov | March 24, 2026 (Mar 24, 2026) |
As of July 20, 2026: Clinical trial NCT07226661 is currently recruiting participants. This phase2 study for major depressive disorder (mdd) is actively seeking new participants at 1 location across the United States. The study is sponsored by Supernus Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07226661 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07226661 was last updated Mar 24, 2026 (March 24, 2026). HelloStudys verifies this status automatically.